Dental

Targeting Surgeons’ Decision-Making for Cleft Lip Surgery

Conditions:   Cleft Palate;   Cleft Lip
Intervention:   Other: Static Images and Facial Videos
Sponsors:   Tufts University School of Dental Medicine;   University of North Carolina, Chapel Hill;   Wake Forest University Health Sciences;   Boston Children’s Hospital;   Massachusetts General Hospital;   Tufts Medical Center;   University of Bath
Recruiting
ClinicalTrials.gov: Dental | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 26, 2018 / by / in
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician’s Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

Condition:   Endometrial Neoplasms
Interventions:   Drug: Pembrolizumab;   Drug: Lenvatinib;   Drug: Paclitaxel;   Drug: Doxorubicin
Sponsors:   Eisai Inc.;   Merck Sharp & Dohme Corp.
Not yet recruiting
ClinicalTrials.gov: Dental | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 8, 2018 / by / in
Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment

Conditions:   Endodontic Disease;   Endodontic Inflammation;   Local Anesthesia;   Dental Anesthesia
Intervention:   Drug: Tetracaine HCl and oxymetazoline HCl nasal spray
Sponsor:   University of North Carolina, Chapel Hill
Not yet recruiting
ClinicalTrials.gov: Dental | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 19, 2018 / by / in
Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

Condition:   Carcinoma, Transitional Cell
Interventions:   Drug: Rogaratinib (BAY1163877);   Drug: Chemotherapy
Sponsor:   Bayer
Not yet recruiting
ClinicalTrials.gov: Dental | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 18, 2018 / by / in